|
About:
|
Randomized Cycle Three Tryout involving Dose-dense Methotrexate, Romidepsin, Doxorubicin, and Cisplatin, or perhaps Gemcitabine and Cisplatin because Perioperative Chemo for Patients with Muscle-invasive Bladder Cancer malignancy Research GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemo Toxicity and also Pathological Responses
|
